AVON, Conn., Oct 25, 2010 (BUSINESS WIRE) -- Magellan Health Services, Inc. (NASDAQ:MGLN) announced today that members of their executive team will present a general overview of the Company and discuss its business strategy at the following upcoming investor conferences:
- Jonathan N. Rubin, chief financial officer , will present at the Oppenheimer 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 9:40 a.m. Eastern.
- René Lerer, M.D., chairman and chief executive officer, will present at the Credit Suisse 2010 Healthcare Conference on Wednesday, November 10, 2010 at 11:30 a.m. Eastern.
Investors and the public are invited to access the conference audio and presentation materials for both conferences via live Webcasts available through Magellan's investor relations page at www.MagellanHealth.com. Those who plan to access a Webcast should log on to the Web site approximately 15 minutes before the scheduled start time of each conference to register and download and install any necessary software. The audio and presentation materials will be available for one week following each presentation.
Those who plan to access a Webcast are encouraged to read Magellan's Annual Report on Form 10-K for the year ended December 31, 2009, filed with the Securities and Exchange Commission on February 26, 2010, and subsequent Quarterly Reports on Form 10-Q, for material information regarding Magellan's operational and financial results, including the section entitled "Risk Factors."
About Magellan: Headquartered in Avon, Conn., Magellan Health Services, Inc., is a leading specialty health care management organization with expertise in managing behavioral health, radiology and specialty pharmaceuticals, as well as public sector pharmacy benefits programs. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. Magellan's customers include health plans, employers and government agencies, serving nearly 60 million people nationwide in our behavioral and radiology benefits lines, more than 40 payors in our specialty pharmaceutical benefits segment, and 25 states and the District of Columbia in our Medicaid Administration segment. For more information, visit www.MagellanHealth.com.
Cautionary Statement: Certain of the statements made in the presentations may constitute forward-looking statements contemplated under the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. These forward-looking statements are based on management's analysis, judgment, belief and expectations as of the date of such statements and are subject to known and unknown uncertainties and risks which could cause actual results to differ materially from those contemplated or implied by such forward-looking statements. Any forward-looking statements made in the presentations are qualified in their entirety by the more complete discussion of risks set forth in the section entitled "Risk Factors" in Magellan's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, filed with the Securities and Exchange Commission. Magellan undertakes no obligation to publicly revise such forward looking statements to reflect events or circumstances that arise after the date of such statements.
SOURCE: Magellan Health Services, Inc.
Magellan Health Services, Inc. Investor Contact: Renie Shapiro, 877-645-6464 or Media Contact: David Carter, 860-507-1909
Copyright Business Wire 2010